Targeted inhibition of mammalian target of rapamycin signaling inhibits tumorigenesis of colorectal cancer

Medicine and Dentistry

• Carcinogenesis 100%
• Colorectal Carcinoma 100%
• Rapamycin 100%
• Mechanistic Target of Rapamycin 100%
• Programmed Cell Death 33%
• Cell Cycle Progression 25%
• Therapeutic Procedure 16%
• Protein 16%
• Growth 16%
• Cancer Cell 16%
• Metabolism 8%
• Small Interfering RNA 8%
• Cytoskeleton 8%
• Cell Proliferation 8%
• Tumor Xenograft 8%
• Phosphoinositide 3-Kinase 8%
• Cell Growth 8%
• Growth Inhibition 8%
• Short Hairpin RNA 8%
• Colorectal Cancer Cell Line 8%
• RNA Interference 8%
• Caco-2 8%
• Therapeutics 8%
• Signal Transduction 8%
• Cell Line 8%

Biochemistry, Genetics and Molecular Biology

• Carcinogenesis 100%
• Mechanistic Target of Rapamycin 100%
• Apoptosis 66%
• Cancer Cell 50%
• Cell Cycle Progression 50%
• Protein 33%
• Growth 33%
• Genetics 16%
• Signal Transduction 16%
• Metabolic Pathway 16%
• RNA Interference 16%
• Small Interfering RNA 16%
• Cytoskeleton 16%
• Cell Proliferation 16%
• Raptor 16%
• Cell Growth 16%
• Small Hairpin RNA 16%
• Phosphoinositide 3-Kinase 16%
• Growth Inhibition 16%

Neuroscience

• Mammalian Target of Rapamycin 100%
• Carcinogenesis 100%
• Sirolimus 100%
• Apoptosis 33%
• Cell Cycle Progression 25%
• In Vivo 16%
• Cell Line 16%
• Protein 16%
• Cell Signaling 8%
• Small Hairpin RNA 8%
• Cytoskeleton 8%
• Cell Proliferation 8%
• Phosphoinositide 3-Kinase 8%
• Metabolic Pathway 8%
• Small Interfering RNA 8%
• Cell Growth 8%